Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Preemptive treatment of de novo donor-specific antibodies in lung transplant patients reduces subsequent risk of chronic lung allograft dysfunction or death

American Journal of Transplantation(2023)10.1016/j.ajt.2022.12.019Source: DataRank Database

Preemptive treatment of de novo donor-specific antibodies in lung transplant patients reduces subsequent risk of chronic lung allograft dysfunction or death is a research paper published in American Journal of Transplantation (2023). On theSindex it has a DataRank of 0.483. It has been cited 24 times.

N/A

0.483DataRank · unranked

Scored on demand from live citation data

Open Access24 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 6.28)OA: bronzeTopics (31)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.483

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (17)

Song Yang ORCID,Lucia Ponor,Ann Bon,A. Cochrane ORCID,Mary Carmelle Philogene ORCID

Live enrichment

PubMed:36732088 PMC:PMC10079558 OpenAlex:https://openalex.org/W4317473422

Intramural NIH HHS

Grant: ZIA HL006268

FWCI

6.28

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

bronzeLicense: http://creativecommons.org/licenses/by-nc-nd/4.0/

journalhttp://www.amjtransplant.org/article/S1600613522302241/pdf

publisherhttp://www.amjtransplant.org/article/S1600613522302241/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1600613522302241?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1600613522302241?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ajt.2022.12.019

Fields of Study

Transplantation: Methods and OutcomesRenal Transplantation Outcomes and TreatmentsViral Infections and Immunology ResearchHumansRetrospective StudiesLungAntibodiesLung TransplantationAllograftsGraft Rejection

MeSH Terms

AntibodiesGraft RejectionHumansLungRetrospective StudiesLung TransplantationAllografts

Keywords

MedicineLungDonor specific antibodiesLung transplantationAntibodyImmunologyTransplantationInternal medicineKidney transplantationRejectionClinical Research/practiceLung Transplantation/pulmonologyLung Transplantation: Living DonorRejection: Antibody-mediated (Abmr)

Sustainable Development Goals

SDG 0: Good health and well-being

Preemptive treatment of de novo donor-specific antibodies in lung transplant patients reduces subsequent risk of chronic lung allograft dysfunction or death

FAIR Checklist

DataRank Breakdown

Authors (17)

Funding (1 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)